David Deepu, Raghavendran Anantharam, Goel Ashish, Bharath Kumar C, Kodiatte Thomas Alex, Burad Deepak, Abraham Priya, Ramakrishna Banumathi, Joseph Philip, Ramachandran Jeyamani, Eapen C E
Department of Gastroenterology, Division of Gastrointestinal Sciences, Christian Medical College and Hospital, Vellore, 632 004, India.
Department of Virology, Christian Medical College and Hospital, Vellore, 632 004, India.
Indian J Gastroenterol. 2017 Sep;36(5):373-379. doi: 10.1007/s12664-017-0785-x. Epub 2017 Oct 4.
The aim of the study was to analyze the prevalence of risk factors for non-alcoholic fatty liver disease (NAFLD) in patients with non-B non-C hepatocellular carcinoma (HCC).
Between June 2012 and November 2014, patients with HCC, negative for hepatitis B surface antigen and hepatitis C virus antibody, were included in this study. All patients were assessed for risk factors for NAFLD such as diabetes mellitus (DM), hypertension, dyslipidemia, metabolic syndrome, and obesity.
Forty-seven patients with non-B non-C HCC (males, 37; age, 60±10 years; mean±SD) were studied. Model for end-stage liver disease score was 11±4. Twenty-five patients were in Child's class A. History of significant alcohol intake was noted in 11 (23%) patients. Prevalence of risk factors for NAFLD were obesity 24 (51%), DM 22 (47%), metabolic syndrome 21 (45%), hypertension 16 (34%), and dyslipidemia 13 (28%). Forty (85%) patients had at least one risk factor for NAFLD. The mean duration of at least one NAFLD risk factor was 7.5 years, prior to diagnosis of HCC. Thirteen (28%) patients were positive for anti-HBc; however, none of the study patients had detectable HBV DNA in blood.
Eighty-five percent of the patients with non-B non-C HCC had at least one risk factor for NAFLD. None of the study patients had occult hepatitis B infection. NAFLD is emerging as the major etiological contributing factor for non-B non-C HCC in India.
本研究旨在分析非B非C型肝细胞癌(HCC)患者中非酒精性脂肪性肝病(NAFLD)危险因素的患病率。
2012年6月至2014年11月期间,纳入乙型肝炎表面抗原和丙型肝炎病毒抗体均为阴性的HCC患者。对所有患者评估NAFLD的危险因素,如糖尿病(DM)、高血压、血脂异常、代谢综合征和肥胖。
研究了47例非B非C型HCC患者(男性37例;年龄60±10岁;均值±标准差)。终末期肝病模型评分11±4。25例患者为Child A级。11例(23%)患者有大量饮酒史。NAFLD危险因素的患病率分别为肥胖24例(51%)、DM 22例(47%)、代谢综合征21例(45%)、高血压16例(34%)和血脂异常13例(28%)。40例(85%)患者至少有一项NAFLD危险因素。在诊断HCC之前,至少一项NAFLD危险因素的平均持续时间为7.5年。13例(28%)患者抗-HBc阳性;然而,本研究所有患者血液中均未检测到HBV DNA。
85%的非B非C型HCC患者至少有一项NAFLD危险因素。本研究所有患者均无隐匿性乙型肝炎感染。在印度,NAFLD正成为非B非C型HCC的主要病因。